JPMorgan upgrades Elanco Animal Health stock to Overweight on innovation cycle
PositiveFinancial Markets

JPMorgan has upgraded Elanco Animal Health's stock to an Overweight rating, highlighting the company's promising innovation cycle. This upgrade is significant as it reflects confidence in Elanco's ability to drive growth through new products and advancements in animal health, which could lead to increased investor interest and potentially higher stock prices.
— Curated by the World Pulse Now AI Editorial System